Astrazeneca Pharma India fundamental analysis
ASTRAZEN
8340
78.50 (-0.93%)Last updated on 9 Jan, 2026 | 15:31 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Astrazeneca Pharma India Fundamentals
P/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
69.98
Sector P/B
0.95
Sec. Div. Yield
0.57
Astrazeneca Pharma India Fundamentals is currently trading with a P/E Ratio of 0, compared to the sector average of 69.98. Its P/B Ratio stands at 0, while the sector’s is 0.95. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.57%.
Astrazeneca Pharma India Score Card
Price
Expensive
Growth
Good
Quality
Average
Management
Good
On its scorecard, Astrazeneca Pharma India reflects: Price – Expensive, Growth – Good, Quality – Average, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
